Monographie - Gemcitabine hydrochloride

Última actualización :
03/05/2024

Gemcitabine hydrochloride

Factores que influyen sobre la estabilidad

Estructura química

Nombre comercial

Los nombres comerciales son orientativos y los excipientes de la formulación pueden ser distintos dependiendo del país y del laboratorio fabricante.

Accogem	México
Antoril	Argentina
Axigem	Alemania
Bendacitabin	Alemania
Binoptos	México
Celzar	Marruecos
Dercin	Rumania
Dhacibine	Malasia
Emcitab	Colombia
Eriogem	Argentina, Ecuador
Fotinex	Argentina, Marruecos
Gebina	Argentina
Gebitan	Colombia
Gembio	Argentina, Chile, Ecuador
Gemcimira	Chile, Marruecos
Gemcit	Portugal
Gemcitabin	Alemania
Gemcitac	Chile
Gemko	Turquía
Gemsibin	Turquía
Gemsol	Austria
Gemtero	Chile, Marruecos
Gemzar	Alemania, Australia, Austria, Bélgica, Brasil, Canadá, Chile, Colombia, Croacia, Dinamarca, Ecuador, Egipto, Emiratos Árabes Unidos, Eslovenia, España, Estados Unidos de América, Finlandia, Francia, Gran Bretaña, Grecia, Hungría, Irán, Irlanda, Islandia, Italia, Luxemburgo, Malasia, Marruecos, México, Noruega, Nueva Zelanda, Países Bajos, Polonia, Portugal, Rumania, Sudafrica, Suecia, Suiza, Tailandia, Túnez, Turquía, Venezuela
Gentabin	Colombia
Haxanit	Argentina, Marruecos
Lenfotabin	México

Bibliografía : Gemcitabine hydrochloride

	Tipo	Publicación
1422	Periódico	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Periódico	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Periódico	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Laboratorio	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Periódico	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Periódico	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Periódico	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Periódico	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Periódico	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Periódico	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Periódico	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Periódico	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Periódico	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Laboratorio	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Periódico	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Laboratorio	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Periódico	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Periódico	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Periódico	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales